Current filters:


Popular Filters

47 to 71 of 1234 results

Recordati finalizes second tranche of Opalia Pharma acquisition


Following previous announcements about its M&A activity, Italian drugmaker Recordati has now announced…

GenericsMergers & AcquisitionsOpalia PharmaRecordatiRest of the World

Congressional hearing in Brazil will discuss the efficacy of generic medicines


The Brazilian Commission for Consumer Protection will soon hold a hearing to discuss the effectiveness…


Indian court ruling lifts temporary stay on Sun Pharma takeover of Ranbaxy


Indian generics drugmaker Sun Pharmaceuticals’ proposed $3.2 billion acquisition of loss-making rival…

Daiichi SankyoGenericsLegalMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceuticals

Prasco to market authorized generic of NeoProfen Injection


Privately held US generic drugmaker Prasco Laboratories has entered into a distribution and supply agreement…

GenericsLicensingNeoProfenNeurologicalPrasco LaboratoriesRecordatiUSA

Russian PM visits country's first commercial manufacturing plant for MAb-based therapeutic proteins


Russian Prime Minister Dmitri Medvedev on Monday visited the commercial manufacturing facility for monoclonal…


Abbott spends $2.9 billion on CFR Pharma to expand Latin American presence


US drugmaker Abbott has signed an agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals,…

Abbott LaboratoriesCFR PharmaceuticalsGenericsMergers & AcquisitionsSouth America

Lilly loses out in UK Alimta vitamin dosage regimen patent law suit


US pharma major Eli Lilly says that the English High Court has determined that the vitamin dosage regimen…

ActavisAlimtaEli LillyGenericsLegalOncologyPatentsUK

Generic drugs will be a key element of Mexico's health care modernization; report


Although Mexico has made great efforts to improve its regulatory framework and create a more hospitable…

GenericsHealthcareMarkets & MarketingMexico

US Court rejects Teva’s Copaxone appeal


A US district court has dismissed a case by Israeli drugmaker Teva Pharmaceutical Industries intended…

CopaxoneGenericsLegalMylanNeurologicalPatentsTeva Pharmaceutical IndustriesUSA

Novartis patent settlement on Gleevec with Sun Pharma subsidiary


The US unit of Swiss drug major Novartis has settled its litigation with the US subsidiary of India’s…

GenericsGleevecNovartisOncologyPatentsSun Pharmaceutical IndustriesUSA

Biocad’s AcellBia is first MAb biosimilar approved by Russia’s Ministry of Health


A biosimilar of Swiss drug major Roche’s MabThera (rituximab), to be marketed under the trade name…


Novasep commissions 4 million-euro plant extension for commercial ADC payload manufacturing


French ingredients company Novasep says that its 4 million-euro ($5.5 million) investment to expand its…


Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved


US generic drugmaker Mylan says it has launched Olanzapine Orally Disintegrating tablets (ODT), 5mg,…

ActavisEli LillyExalgoGenericsMallinckrodtMarkets & MarketingMylanNeurologicalRegulationUSAZyprexa

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma


Germany-based Fresenius Kabi has entered into an agreement to acquire the privately held Brazilian pharmaceutical…

BrazilFresenius KabiGenericsMergers & AcquisitionsNovafarma Industria Farmaceutica

Akorn to acquire VersaPharm for $440 million

Akorn to acquire VersaPharm for $440 million


Following swiftly on its completion of the acquisition of Hi-Tech Pharmacal (Nasdaq: HITK) for $640 million…

AkornDermatologicalsGenericsMergers & AcquisitionsVersaPharm

Vivus says Actavis has filed ANDA for generic Qsymia

Vivus says Actavis has filed ANDA for generic Qsymia


US drug developer Vivus disclosed on Friday that the company had received notice from generics major…


Actavis debuts generic copy of Catapres-TTS

Actavis debuts generic copy of Catapres-TTS


Ireland-headquartered generics major Actavis has launched a generic version of German family-owned pharma…

ActavisBoehringer IngelheimCardio-vascularCatapres-TTSGenericsMarkets & MarketingUSA

Grunenthal strengthens pain product portfolio with European rights to etoricoxib


Family-owned German drugmaker Grunenthal Group today announced the signing of an exclusive promotion…

etoricoxibEuropeGenericsGrunenthalLicensingMerck & CoNeurological

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

Australian Audit Commission’s “nuclear option to attack the PBS is madness”


The Australian National Commission of Audit’s complete dismantling and destruction of the Pharmaceutical…


Sun Pharma vows “appropriate action” as Ranbaxy merger halted


In the wake of a suspension of its proposed $4 billion acquisition of domestic rival Ranbaxy Laboratories…

GenericsIndiaMergers & AcquisitionsProductionRanbaxy LaboratoriesSun Pharmaceutical IndustriesUSA

FTC Amicus Brief urges Court of Appeals to reverse DC ‘No-Authorized Generic’ commitments ruling


The US Federal Trade Commission filed an Amicus Brief in the US Court of Appeals for the Third Circuit,…


Teva 1st-qtr 2014 boosted by new generics

Teva 1st-qtr 2014 boosted by new generics


Israel generic giant Teva Pharmaceutical Industries reported a 2% rise in revenues to $5.0 billion for…

FinancialGenericsTeva Pharmaceutical Industries

47 to 71 of 1234 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top